Pykus

GelMEDIX

GelMEDIX develops injectable hydrogel scaffolds and regenerative cell therapies to treat degenerative ocular diseases such as geographic atrophy for patients with vision loss.

InGel Therapeutics

The company develops stem-cell therapies and biodegradable hydrogels for patients suffering from retinal degeneration and blinding diseases like retinitis pigmentosa.

InGel

This biotechnology company develops engineered cell therapies and biodegradable polymers to treat retinal degeneration for patients with blinding eye diseases.

Pixium Vision

This company develops bionic vision restoration systems and retinal implants for patients who have lost their sight due to degenerative eye diseases.

oculex-pharmaceuticals

This company develops biodegradable intraocular implants and drug delivery systems to treat retinal diseases for patients with conditions such as macular oedema.

Neuro Modulation Artificial Retina

This company develops a high-acuity spherical bionic retinal implant to restore vision for patients with retinitis pigmentosa or age-related macular degeneration.

Perfuse Therapeutics

The company develops sustained-release intravitreal therapies to treat ischemia-driven ocular diseases for patients with conditions like glaucoma and diabetic retinopathy.

BioLattice

This company develops synthetic corneal implants to restore vision for patients with corneal blindness who lack access to donor tissue.